Structures by: Cirqueira M. D.
Total: 7
C21H23ClFNO2
C21H23ClFNO2
Molecular pharmaceutics (2017) 14, 4 1278-1291
a=7.7503(3)Å b=8.9174(4)Å c=26.8821(11)Å
α=90° β=90.435(2)° γ=90°
C25H27ClFNO6
C25H27ClFNO6
Molecular pharmaceutics (2017) 14, 4 1278-1291
a=27.621(9)Å b=11.002(3)Å c=15.786(5)Å
α=90° β=102.120(13)° γ=90°
Lamivudine hydrogen hemihydrate phthalate
2(C8H12N3O3S),2(C8H5O4),H2O
CrystEngComm (2013) 15, 32 6311
a=5.3110(5)Å b=21.103(2)Å c=33.059Å
α=90° β=94.675(6)° γ=90°
Lamivudine 4,5-dichloro hydrogen phthalate
C8H12N3O3S,C8H3Cl2O4
CrystEngComm (2013) 15, 32 6311
a=8.9680(3)Å b=10.3880(4)Å c=11.4140(4)Å
α=99.427(3)° β=112.791(2)° γ=90.988(3)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one 1,2-bis(4-pyridyl)ethene cocrystal
C40H28Cl2F6N4O4
Crystal Growth & Design (2013) 13, 4 1558
a=5.1586(6)Å b=8.9072(9)Å c=20.768(2)Å
α=86.317(7)° β=86.355(7)° γ=73.313(7)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one 1,2-bis(4-pyridyl)ethane cocrystal
C40H30Cl2F6N4O4
Crystal Growth & Design (2013) 13, 4 1558
a=5.3101(4)Å b=8.6465(5)Å c=20.7050(14)Å
α=84.956(4)° β=85.946(4)° γ=74.581(4)°
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1- benzoxazin-2-one
C14H9ClF3NO2
Crystal Growth & Design (2013) 13, 4 1558
a=16.656(7)Å b=5.312(2)Å c=17.227(7)Å
α=90° β=113.59(3)° γ=90°